France Bans Oral Nicotine Products in Forms of Pouches, Pastes, Tablets, and Liquids Starting March 2026

Sep.08.2025
France Bans Oral Nicotine Products in Forms of Pouches, Pastes, Tablets, and Liquids Starting March 2026
France's Decree No. 2025-898 bans all oral nicotine products nationwide six months after publication. Medicines and medical devices are exempt. This includes nicotine pouches, gum, lozenges, and other forms, regardless of origin. The decree is based on the Public Health Code and applies to mainland France and Wallis and Futuna Islands.

Key Points:

 

·Ban Scope: The production, manufacture, transport, import, export, possession, offer/sale, purchase, and use of these products are prohibited within France.

·Formats include: nicotine pouches (including porous pouches), pastes, beads, liquids, chewing gum, lozenges, films/strips, etc. (regardless of whether the nicotine is natural or synthetic).

·Exemptions:
1. Chewing tobacco;
2. Legally approved pharmaceuticals, medical devices, and their medicinal raw materials;
3. Food (naturally containing trace amounts of nicotine or meeting EU pesticide residue limits).

·Research Exceptions: Case-by-case exemptions for research purposes may be issued by the Minister of Health, subject to separate conditions and procedures.

·Effective Date: Le Monde and Radio France Internationale reported that the ban will officially take effect in March 2026.

 


 

2Firsts, September 8, 2025 - According to the French government's official website on September 5, the French government published Decree No. 2025-898 in the Official Gazette, which will take effect six months from its publication. This ban applies nationwide to the production, sale, possession, purchase, and use of "nicotine-containing products for oral use," with the exception of medicines and medical devices.

 

The decree specifies that the ban covers all stages of the process: production, manufacturing, transportation, import/export, possession, provision/transfer, purchase, and actual use.

 

Formats subject to the ban include:

 

Nicotine pouches (including porous pouches), pastes, beads, liquids, chewing gum, lozenges, films/strips, and more (regardless of whether the nicotine is natural or synthetic).

 

Exemptions include:

 

·Chewing tobacco;

·Legally approved medicines, medical devices, and their medicinal raw materials;

·Food (naturally containing nicotine or meeting EU pesticide residue limits).

 

The decree provides for scientific research exceptions, which can be granted for specific research projects upon the signature of the Minister of Health and in compliance with specified conditions.

 

The background document states that nicotine is classified as a "toxic substance" under the French Public Health Code, allowing for a ban on "any related operation" by decree of the Council of State. The decree has also been submitted to the European Union for technical regulatory information (notification number 2025/0110/FR) as required.

 

The decree indicates that, in addition to mainland France, the relevant provisions also apply to the Wallis and Futuna Islands.

 

Le Monde and Radio France Internationale reported that the ban will officially take effect in March 2026.

 

2Firsts First Look|China to End VAT Export Rebates on Vape Devices and Nicotine in April 2027, Following Earlier Removal for HTP Devices and Nicotine Vapes
2Firsts First Look|China to End VAT Export Rebates on Vape Devices and Nicotine in April 2027, Following Earlier Removal for HTP Devices and Nicotine Vapes
China's Ministry of Finance and State Taxation Administration announced on October 12, 2026, that value-added tax (VAT) export rebates for vape devices, nicotine and its salts, and certain non-combustible inhalation products will be eliminated from April 1, 2027. The measure adds four tobacco- and nicotine-related customs codes, including 8543400010, which covers vape devices and qualifying empty pods. China previously eliminated rebates for nicotine-containing vaping products and devices under code 8543400090 in April 2026. According to industry classification information held by 2Firsts, the latter currently corresponds to heated tobacco devices. Export excise tax refund and exemption arrangements will remain unchanged.
Special Report
Oct.12
Reynolds Puts Nearly 183,000 U.S. Contracted Outlets Under Age-Verification Rules, Covering 94% of Volume — Can It Shift an Unauthorized Vape Market?
Reynolds Puts Nearly 183,000 U.S. Contracted Outlets Under Age-Verification Rules, Covering 94% of Volume — Can It Shift an Unauthorized Vape Market?
Reynolds American says nearly 183,000 U.S. retail outlets are under contract, with its Retail Marketing Plan Contract covering about 94% of company volume and requiring point-of-sale age verification. The company combines those contracts with We Card, TruAge, NACS-linked infrastructure and POS integration, while enhanced Vuse Pro retail rules add ID scanning, purchase limits and stronger underage-sales accountability. The initial Vuse Pro rollout targets about 50,000 stores. The system is taking shape as unauthorized vapor products remain dominant in parts of the U.S. market: a 2026 study estimated they accounted for 69.4% of tracked brick-and-mortar e-cigarette dollar sales in December 2025.
Special Report
Oct.15
Product | KT&G Launches lil HYBRID 3.0 Misty Rosé Edition II in South Korea With Two Pink Finishes at 88,000 Won
Product | KT&G Launches lil HYBRID 3.0 Misty Rosé Edition II in South Korea With Two Pink Finishes at 88,000 Won
South Korean tobacco company KT&G launched the limited-edition lil HYBRID 3.0 Misty Rosé Edition II on September 30, 2026, following the original Misty Rosé Edition introduced in November 2025. The new release comes in two pink finishes, Bloom Rosé and Viva Rosé, each priced at 88,000 won. Both versions initially went on sale through the lil Store online shop and lil MINIMALIUM flagship stores. From October 7, Bloom Rosé became available at approximately 1,500 lil Station retail outlets nationwide. The release retains the existing lil HYBRID 3.0 hybrid heated tobacco platform, with changes focused on exterior design and distribution.
product
Oct.10
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
South Korea Extends Vape Rules to Unmanned Stores After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Extends Vape Rules to Unmanned Stores After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's Ministry of Gender Equality and Family said on September 14 that it plans to designate unmanned e-cigarette stores as businesses where minors are prohibited from entering or working. Operators would be required to verify customers' ages and display notices restricting access by minors. The proposal is open for public comment through October 6. The move follows an April expansion of South Korea's statutory tobacco definition that brought products made with natural or synthetic nicotine under the Tobacco Business Act. Nicotine-free liquids and products using nicotine analogues such as 6-methylnicotine, however, remain an emerging regulatory issue.
Sep.21
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10